Skip to main content

Syndicate contentAlzheimer's

Upending textbook science on Alzheimer's disease

Alzheimer's disease is caused by the build-up of a brain peptide called amyloid-beta. That's why eliminating the protein has been the focus of almost all drug research pursuing a cure for the devastating neurodegenerative condition.

An atomic-level look at an HIV accomplice

ANN ARBOR, Mich.---Since the discovery in 2007 that a component of human semen called SEVI boosts infectivity of the virus that causes AIDS, researchers have been trying to learn more about SEVI and how it works, in hopes of thwarting its infection-promoting activity.

AFFiRiS AG: Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing

November 19, 2009 by prandd

Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing

New neuroimaging analysis technique identifies impact of Alzheimer's disease gene in healthy brains

Amsterdam, November 17, 2009 -- Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD.

Protein changes in heart strengthen link between Alzheimer's disease and chronic heart failure

A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.

Researchers find potential treatment for Huntington's disease

Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins asso

CSHL team solves structure of NMDA receptor unit that could be drug target for neurological diseases

Cold Spring Harbor, NY -- A team of scientists at Cold Spring Harbor Laboratory (CSHL) reports on Thursday their success in solving the molecular structure of a key portion of a cellular receptor i

Mouse gene suppresses Alzheimer's plaques and tangles

Investigators at Burnham Institute for Medical Research (Burnham) and colleagues have identified a novel mouse gene (Rps23r1) that reduces the accumulation of two toxic proteins that are major play

Study sheds light on evolution of human complexity

A painstaking analysis of thousands of genes and the proteins they encode shows that human beings are biologically complex, at least in part, because of the way humans evolved to cope with redundancie

Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk

SAN FRANCISCO -- Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Opht

AFFiRiS AG: Encouraging Results from Phase I Studies of Two Alzheimer's Candidate Vaccines Trigger EUR 10 Mio. Milestone Payment

October 20, 2009 by prandd

Vienna, 20. October 2009: AFFiRiS AG today announced that the primary endpoints have been met for the Phase I clinical studies of its two Alzheimer's vaccines AD01 and AD02, which demonstrated favourable safety and tolerability profiles. These results trigger a 10 million EUR milestone payment from licensee GlaxoSmithKline Biologicals.

Smart rat 'Hobbie-J' produced by over-expressing a gene that helps brain cells communicate

AUGUSTA, Ga. -- Over-expressing a gene that lets brain cells communicate just a fraction of a second longer makes a smarter rat, report researchers from the Medical College of Georgia and East China Normal University.

APP -- Good, bad or both?

CHICAGO -- New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development. So is APP good or bad? Researchers at Georgetown University Medical Center say both, and that a balance of APP is critical.

Yerkes researchers present at 39th Annual Society for Neuroscience Conference

Neuroscience researchers from the Yerkes National Primate Research Center, Emory University, will present a wide range of research topics at the Society for Neuroscience's 39th annual meeting in Chicago, Oct. 17-21, 2009. The information below is a representation of the neuroscience research Yerkes scientists will be discussing.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes